ribociclib,palbociclib
novartis,pfizer
['breast', ' ribo', 'palbo']
sonia trial did not prove the superiority of 1st line cdk4-6 inhibitor imbalance of palbo and ribo, et sensitivity #asco23 #breastcancer 
I am a medical oncologist. My areas of expertise are breast cancer, sarcoma, gynecologic cancer, urologic cancer, and rare cancers.